Julio Martin and his colleagues at the Tres Cantos GSK Open Laboratory are working collaboratively on diseases like African Sleeping Sickness, Chagas Disease, Leishmaniasis, Tuberculosis, and Malaria in an industrial environment. Michael Pollastri brings big pharma experience to multi-center academic collaborations. Their experiences are relevant for both commercial and neglected disease drug discovery. They are both experimenting while pushing boundaries in new modes combining sensitive and open data.

Learn about GSK and Northeastern’s work directly together, and separately with dozens of leading researchers around the world. These unique approaches to collaboration and science suggest a more efficient paradigm that one day may become the status quo.